Biotech’s Next Generational Breakout

An answer to myeloid leukemia could be imminent with over 773 percent potential upside, according to an HC Wainwright Analyst. Take a moment to learn why Actinium Pharmaceuticals might be behind biotech’s next generational leap forward.

Faster, Easier Cancer Detection

Early detection is key when it comes to treating cancer. Let’s take a look at how this company is breaking new ground in a $3.7 billion market with faster and easier methods of colorectal cancer screening.

The Next Big Biotech Breakout

The Tobacco Revolution Is Happening Plant Biotech Disruptor, 22nd Century Group, Inc. (NASDAQ: XXII), Is Shocking the Tobacco Market with the Newest FDA Approval Build your watchlist with us Get the latest stock ideas direct to your inbox. 100% free and your information stays with us. SUBMIT !function(){function t(t){this.element=t,this.animationId,this.start=null,this.init()}if(!window.requestAnimationFrame){var i=null;window.requestAnimationFrame=function(t,n){var e=(new Date).getTime();i||(i=e);var a=Math.max(0,16-(e-i)),o=window.setTimeout(function(){t(e+a)},a);return i=e+a,o}}t.prototype.init=function(){var t=this;this.animationId=window.requestAnimationFrame(t.triggerAnimation.bind(t))},t.prototype.reset=function(){var… Continue reading The Next Big Biotech Breakout

Cancer Breakthrough Of The Decade

Today, we’re looking at a biotech company that is looking to change the way we treat cancer with its groundbreaking, highly innovative technologies. There’s no question: This is absolutely a great stock to watch.